Janssen Pharmaceuticals (JNJ) Receives sNDA for NUCYNTA ER for Pain Associated with Diabetic Peripheral Neuropathy

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/21/2026

1. WMT
2. ROST
3. AAP
4. NVDA
5. SPY
6. AVGO
7. SPCX
8. BJ
9. BABA
10. OSIS

Go back to Janssen Pharmaceuticals (JNJ) Receives sNDA for NUCYNTA ER for Pain Associated with Diabetic Peripheral Neuropathy
Johnson & Johnson (NYSE: JNJ) Delayed: 270.24 +2.87 (1.07%)
Previous Close $267.37    52 Week High $126.07 
Open $267.83    52 Week Low $94.28 
Day High $272.66    P/E 56.18 
Day Low $267.00    EPS $4.81 
Volume 6,175,149